Drug Database
Back to search

Netherlands· NL-629fe4880806

Lisdexamfetamine Aristo 10 mg/ml drank

A lisdexamfetamine product containing lisdexamfetaminedimesilaat, registered in Netherlands by Aristo Pharma GmbH. The same ATC class is registered in 15 of our 19 countries.

ATC N06BA12

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedLisdexamfetamine Aristo 10 mg/ml drankATCN06BA12REGISTER NO.NL-629fe4880806PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lisdexamfetaminedimesilaatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lisdexamfetamine is registered in 15 of 19 countries.

Countries holding a registration under ATC N06BA12 (lisdexamfetamine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search lisdexamfetamine products by name

Lisdexamfetamine · ATC N06BA12

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lisdexamfetamine costs, country by country.

Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Lisdexamfetamine · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
LISDEXAMFETAMINEDIMESILAAT
Manufacturer
Aristo Pharma GmbH
Country
Netherlands (NL)
ATC code
N06BA12
ATC class
Lisdexamfetamine
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    129024

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

217 interactions on record for lisdexamfetamine.

Graded by severity as the source publishes them — 51 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lisdexamfetamine against other medicinesHow interaction checks work

Lisdexamfetamine · interactions on record

217 records

  • 51 severe
  • 164 moderate
  • 2 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • FenfluramineA08AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under N06BA12

Lisdexamfetamine, as other registers publish it.

All lisdexamfetamine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f051bc8b-3ab4-405d-af71-61cb82031e62
GET /v1/drugs/f051bc8b-3ab4-405d-af71-61cb82031e62?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Drank",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h129024_smpc_en.pdf",
  "strength": null,
  "atc_label": "Lisdexamfetamine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg129024",
  "excipients": [
    "DINATRIUMWATERSTOFFOSFAAT 2-WATER (E 339)",
    "NATRIUMDIWATERSTOFFOSFAAT 2-WATER (E 339)",
    "NATRIUMHYDROXIDE (E 524)",
    "NATRIUMMETHYLPARAHYDROXYBENZOAAT (E 219)",
    "NATRIUMPROPYLPARAHYDROXYBENZOAAT",
    "PROPYLEENGLYCOL (E 1520)",
    "SACCHAROIDE NATRIUM X-WATER (E 954)",
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "LISDEXAMFETAMINEDIMESILAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h129024_piluk.pdf",
  "authorised_at": "2024/05/22",
  "procedure_number": "MT/H/0618/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "129024",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about lisdexamfetamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console